These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17892356)

  • 1. FibroMAX: towards a new universal biomarker of liver disease?
    Morra R; Munteanu M; Imbert-Bismut F; Messous D; Ratziu V; Poynard T
    Expert Rev Mol Diagn; 2007 Sep; 7(5):481-90. PubMed ID: 17892356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FibroTest-FibroSURE: towards a universal biomarker of liver fibrosis?
    Poynard T; Imbert-Bismut F; Munteanu M; Ratziu V
    Expert Rev Mol Diagn; 2005 Jan; 5(1):15-21. PubMed ID: 15723588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease.
    Thabut D; Naveau S; Charlotte F; Massard J; Ratziu V; Imbert-Bismut F; Cazals-Hatem D; Abella A; Messous D; Beuzen F; Munteanu M; Taieb J; Moreau R; Lebrec D; Poynard T
    J Hepatol; 2006 Jun; 44(6):1175-85. PubMed ID: 16580087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Distribution of Liver Steatosis, Fibrosis, Steatohepatitis and Inflammation Activity in Alcoholics According to FibroMax Test.
    Gudowska M; Wojtowicz E; Cylwik B; Gruszewska E; Chrostek L
    Adv Clin Exp Med; 2015; 24(5):823-7. PubMed ID: 26768633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia.
    Ratziu V; Giral P; Munteanu M; Messous D; Mercadier A; Bernard M; Morra R; Imbert-Bismut F; Bruckert E; Poynard T
    Aliment Pharmacol Ther; 2007 Jan; 25(2):207-18. PubMed ID: 17229244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver biopsy versus noninvasive methods--fibroscan and fibrotest in the diagnosis of non-alcoholic fatty liver disease: a review of the literature.
    Pais R; Lupşor M; Poantă L; Silaghi A; Rusu ML; Badea R; Dumitraşcu DL
    Rom J Intern Med; 2009; 47(4):331-40. PubMed ID: 21179914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity.
    Lassailly G; Caiazzo R; Hollebecque A; Buob D; Leteurtre E; Arnalsteen L; Louvet A; Pigeyre M; Raverdy V; Verkindt H; Six MF; Eberle C; Patrice A; Dharancy S; Romon M; Pattou F; Mathurin P
    Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):499-506. PubMed ID: 21499110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-alcoholic steato-hepatitis].
    Linhart HG
    Praxis (Bern 1994); 2000 May; 89(22):963-6. PubMed ID: 10893995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
    Munteanu M; Ratziu V; Morra R; Messous D; Imbert-Bismut F; Poynard T
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):187-91. PubMed ID: 18568141
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery.
    Trak-Smayra V; Dargere D; Noun R; Albuquerque M; Yaghi C; Gannagé-Yared MH; Bedossa P; Paradis V
    Gut; 2009 Jun; 58(6):825-32. PubMed ID: 18403495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of protein tyrosine phosphatase 1B and insulin receptor immunostains to differentiate nonalcoholic from alcoholic steatohepatitis in liver biopsy specimens.
    Sanderson SO; Smyrk TC
    Am J Clin Pathol; 2005 Apr; 123(4):503-9. PubMed ID: 15743753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.
    Itoh S; Yougel T; Kawagoe K
    Am J Gastroenterol; 1987 Jul; 82(7):650-4. PubMed ID: 3605026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
    Castera L
    J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia.
    Dolmazashvili E; Zhamutashvili M; Svanidze M; Nizharadze N; Abutidze A
    Georgian Med News; 2008 Dec; (165):83-7. PubMed ID: 19124923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive assessment of chronic liver and gastric diseases.
    Plebani M; Basso D
    Clin Chim Acta; 2007 May; 381(1):39-49. PubMed ID: 17374528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of hepatitis with special reference to the viral form].
    Fábregas Rodríguez C; Hurtado de Mendoza Amat J; Alvarez Blanco J
    Rev Cubana Med Trop; 1980; 32(3):211-8. PubMed ID: 6454226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and therapy of nonalcoholic steatohepatitis.
    Torres DM; Harrison SA
    Gastroenterology; 2008 May; 134(6):1682-98. PubMed ID: 18471547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    Sebastiani G; Vario A; Guido M; Alberti A
    J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
    Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
    J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.